May 3, 2017
Novo Nordisk reports 10% profit increase for Q1 2017
Novo Nordisk has reported profit of €1.4 billion for the first quarter of 2017, which is increase of 10%.
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
May 3, 2017
Sobi with new haemophilia research office in Greece
Swedish Orphan Biovitrum (Sobi) will open a new office in Athens, Greece.
April 28, 2017
Novartis’s oncology department gets FDA’s OK for two indications
Novartises Rydapt has been approved by the FDA for the treatment of acute myeloid leukemia, and for treating adults with advanced systemic mastocytosis.
April 28, 2017
Sanofi kicks off year with robust growth driven by Specialty Care and Vaccines
Sanofi Chief Executive Officer, Olivier Brandicourt, said that the company has started the year with robust growth driven by Specialty Care and Vaccines as well as good performance in Emerging Markets.
April 28, 2017
US FDA to review biologics license application resubmission for Kevzara
Sanofi and Regeneron Pharmaceuticals have resubmitted their Biologics License Application for Kevzara, which is an investigational human monoclonal antibody to be used for treatment of rheumatoid arthritis (RA) with adult patients.
April 27, 2017
AstraZeneca hopes to escape drug sales trough in second half
AstraZeneca, struggling with loss of patents on blockbusters like cholesterol pill Crestor, reported another quarter of falling drug sales on Thursday as it awaits pivotal clinical trial data that may revive its fortunes.
April 27, 2017
South Korea fines Novartis $49 million over kickbacks, suspends insurance payment
South Korea said on Thursday it has fined Swiss drugmaker Novartis 55.1 billion won ($48.80 million) for offering doctors kickbacks to recommend the company’s drugs, and also suspended insurance coverage for some of its drugs.
April 27, 2017
Drugs firms call for phased transition of regulation after Brexit
Pharmaceutical companies called on Thursday for a phased transition in drug regulation after Britain leaves the European Union, in order to avoid supply disruption and protect public health.
April 27, 2017
Human forebrain circuits under construction – in a dish
National Institutes of Health (NIH)-funded neuroscientists have created a 3D window into the human brain’s budding executive hub assembling itself during a critical period in prenatal development. What’s more, they used it to discover and experimentally correct — in a petri dish — defective cell migration caused by an autism-related disorder.
April 27, 2017
Bayer reports 38% higher profit in Q1 2017
Bayer has reported net income of €2.083 million for Q1 2017 which is 37.9 percent higher comparing the same period last year.